TLX 1.65% $18.44 telix pharmaceuticals limited

the news wires report R&D blowout ...but R&D as a percentage of...

  1. 1,582 Posts.
    lightbulb Created with Sketch. 672
    the news wires report R&D blowout ...

    but R&D as a percentage of sales decreased from 28% to 26% (someone clarify me if im wrong pls)

    so doesn't really make sense why the stock boomed in April 2023 on higher % of sales spend on R&D

    and back then everyone got excited over a $100m quarter which we were all expecting.

    doesnt really matter, it will go when it goes .... this UBS report is interesting.
    as far as im concerned there's $100m in cash sitting there and CB did say the imaging was merely to pay for the Therapies which is where the big money sits. so he can spend it

    but reality is that Full Year finished Dec 31 and there's another $100m that's already come in the door in sales

    if TLX can clock in a Billion in sales this year at 60% Gross margin , thats $600m

    ...... $600m minus $200m R&D is still $400m

    If TLX can clock in $2 Billion in sales at 60% Gross margin , thats $1.2 Billion (current 63% and Zircaix i think he said was closer to 70%)

    .... $1.2 Billion minus $200m R&D is ....

    what a wonderful position to be in ... not one cash cow, but soon to be three cash cows
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
(20min delay)
Last
$18.44
Change
0.300(1.65%)
Mkt cap ! $6.161B
Open High Low Value Volume
$18.25 $18.46 $17.91 $42.70M 2.328M

Buyers (Bids)

No. Vol. Price($)
1 5117 $18.41
 

Sellers (Offers)

Price($) Vol. No.
$18.44 42145 6
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.